New method helps gain fundamental insights into ribosome function

NewsGuard 100/100 Score

Inside tiny cellular machines called ribosomes, chains of genetic material called messenger RNAs (mRNAs) are matched with the corresponding transfer RNAs (tRNAs) to create sequences of amino acids that exit the ribosome as proteins. Unfinished proteins are called nascent chainsm and they are left attached to the ribosome.

Scientists know that some of these nascent chains can regulate the activity of the ribosome and that the nascent chains can sometimes interfere with antibiotics -; many of which work by targeting bacterial ribosome activity. Scientists do not know why this happens, mainly because it is hard to visualize what the ribosome-peptide-drug interactions look like while the unfinished proteins are still tethered to the ribosome.

Now, scientists at the University of Illinois Chicago are the first to report a method for stable attachment of peptides to tRNAs, which has allowed them to gain new fundamental insights into ribosome function by determining the atomic-level structures of ribosomes and the shapes that these peptides take inside the ribosome.

Their method is newly reported in the journal Nature Chemistry.

The challenge has been to see up close the structure of the ribosome and the exit tunnel in the presence of the nascent peptides because, in nature, the ribosome is very quick for us to capture images or conduct experiments. Until the advent of this new method, we've essentially been blinded from seeing what is happening in the active site of the ribosome at this critical moment in time."

Yury Polikanov, associate professor in the biological sciences department at the College of Liberal Arts and Sciences

Polikanov and his colleague Egor Syroegin, a PhD candidate in biological sciences at UIC, used a method called native chemical ligation to fuse custom peptides with the tRNA to yield what is called a peptidyl-tRNA.

"Obtaining tRNA molecules linked to peptides, similar to those inside the ribosome during protein synthesis, has remained a dream of many researchers in the field for almost two decades," Polikanov said. "This has been extremely challenging because there are no enzymes that can directly attach peptides to a tRNA."

"The method has been used for a long time in chemistry, but it has never been applied in this way. It's mimicking nature, basically, and with our advanced imaging experience, we are now seeing how nature works at a high resolution," Syroegin said.

With this new approach, Polikanov and Syroegin determined a set of high-resolution structures of the ribosome carrying peptidyl-tRNAs of various lengths.

Detailed analysis of these structures provides new and surprising insights into the mechanism of the ribosome's catalytic center and answered several long-standing fundamental questions in the ribosome field, Polikanov said.

"We saw that depending on the sequence, different peptides can form different shapes or folds within the ribosomal tunnel, and we can synthesize different peptides of different sequences and then follow their shape very precisely, because of the high resolution of our structures," Syroegin said. "So now, we can very confidently say that 'these peptides, of this sequence, have this shape' or 'another peptide has another shape.' That's important because nascent peptide folding determines whether drugs would arrest ribosome or not."

"This method opens countless avenues for structural and functional studies aimed at understanding the mechanisms of ribosome functioning, as well as sequence-specific ribosome stalling induced by certain antibiotics," Polikanov said.

Journal reference:

Syroegin, E.A., et al. (2022) Insights into the ribosome function from the structures of non-arrested ribosome-nascent chain complexes. Nature Chemistry.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Understanding the role of genetic variants in male infertility